District of Columbia MPJE Exam Prep

Enrollment open: 1,500 original practice questions built on NABP’s official MPJE Competency Statements. Enroll today and start with the free sample exam.

The District of Columbia MPJE — the Multistate Pharmacy Jurisprudence Examination as administered for District licensure — tests federal pharmacy law and District of Columbia pharmacy law in a single sitting, with no distinction between them: where the District rule and the federal rule differ, the District rule is the one the question is answered under. PassProfessor’s District of Columbia MPJE program prepares you with 1,500 original practice questions built exactly that way — an 800-question federal core intermixed with 700 District-specific questions grounded in the Health Occupations Revision Act, the pharmacy facility and prescription rules, the District’s Controlled Substances Act, its substitution law and its prescription drug monitoring law — weighted to NABP’s current Competency Statements.

What the program covers

Every competency area on NABP’s current MPJE Competency Statements is covered at its published weight. The bank’s question count in each area, and what a full practice exam draws from each:

  • Licensure and Personnel — 333 practice questions; 22 per full practice exam
  • Pharmacist Practice — 498 practice questions; 33 per full practice exam
  • Dispensing Requirements — 358 practice questions; 24 per full practice exam
  • Pharmacy Operations — 311 practice questions; 21 per full practice exam

A full practice exam draws 100 scored questions — the scored length of the real exam — across all four competency areas at their published weights, inside a 150-minute limit that mirrors the real 2.5-hour clock. The real exam administers 120 questions: the same 100 scored questions plus 20 unscored pretest questions mixed in; this program’s draws are scored questions only. Practice exams are scored against a 70% practice benchmark: the real MPJE is pass/fail and NABP does not publish a raw passing score, so treat the benchmark as a practice target, not an NABP standard.

How the program works

Enroll once and the full course opens: full-length practice exams, a free 20-question sample to start with, and per-topic drills for focused work on the competency areas you want to strengthen. Every practice exam draws a fresh set of questions, so repeat attempts keep testing rather than repeating. Every question in the program includes an explanation of why the keyed answer is right.

District of Columbia MPJE at a glance

  • Questions on the real exam: 120 administered (100 scored + 20 unscored pretest)
  • Time limit: 2.5 hours
  • Format: computer-based at Pearson VUE; federal and District of Columbia questions intermixed, with no distinction between them
  • Scoring: pass/fail — NABP does not publish a raw passing score
  • Attempts: up to 5 per jurisdiction
  • Fees: about $270 per attempt in NABP fees
  • Eligibility: confirmed by NABP — the District of Columbia is one of the short list of jurisdictions for which NABP itself confirms eligibility
  • Score transfer: MPJE scores are not transferable between jurisdictions — a District of Columbia pass applies to District licensure

The District of Columbia law behind the exam

Half of what makes the District of Columbia MPJE hard is that it is two bodies of law at once. The District half of this program is built on:

  • The District of Columbia questions in this bank are grounded in primary District sources read first-hand: the Health Occupations Revision Act (Title 3 of the D.C. Code, including the pharmacy provisions and the pharmacy technician subchapter), the pharmacy facility and prescription rules (Title 22-B of the District of Columbia Municipal Regulations, Chapters 19 and 13), the individual-licensure rules (Title 17 DCMR Chapters 65, 99 and 103), the Controlled Substances Act (Title 48, Chapter 9), the generic-substitution law (Title 48, Chapter 8, Subchapter III), and the Prescription Drug Monitoring Program law (Title 48, Chapter 8G). The District splits its two licensing functions, and the exam tests them separately: individual pharmacists are licensed by the Board of Pharmacy, while pharmacy facilities are licensed through the Director of the Department of Health.
  • The District’s prescription drug monitoring program reaches beyond the controlled-substance schedules: alongside Schedule II–V dispensing, products containing gabapentin, butalbital or cyclobenzaprine are reportable as drugs of concern. A dispenser reports within 24 hours of dispensing — and files a zero report for any 24-hour period with no covered dispensing. The check duty binds dispensers as well as prescribers: before dispensing an opioid or benzodiazepine for an anticipated course of more than 7 days, and before a refill more than 90 days after the initial fill or the previous refill, the program must be checked; prescribers run the same check before starting a course of more than 7 days and every 90 days during therapy. A prescriber or dispenser may register at most two delegates.
  • District substitution law is permissive, with a purchaser’s edge: a pharmacist may substitute a generically equivalent drug or an interchangeable biological product, and must substitute when the purchaser asks. Any substitution — and any prescription written by generic name — must be filled with the in-stock product at the lowest cost to the purchaser. A prescriber’s do-not-substitute direction counts only in the prescriber’s own handwriting on a signed order; a checked or initialed preprinted box is expressly invalid. For an interchangeable biologic, the prescriber must be told the specific product dispensed and its manufacturer within 5 business days after dispensing, unless no interchangeable product is approved for the drug prescribed or the refill is unchanged.
  • The District schedules controlled substances its own way. The Mayor schedules by rule, and following a federal scheduling action is permitted, not automatic. In the D.C. Code itself, cannabis sits in Schedule III and buprenorphine in Schedule V — placements that differ from federal law, so on this exam the federal answer can be the wrong answer. Controlled-substance registration is annual, renewal is filed at least 60 days before expiration or the registration abates, and pharmacies register as dispensers — there is no pharmacy exemption. Three District dispensing rules draw questions every cycle: over-the-counter Schedule V sales are capped per purchaser per 48 hours, sold only by a pharmacist to a purchaser 18 or older and recorded in a bound logbook; Schedule III–V prescription information may be transferred between pharmacies only once; and an emergency oral Schedule II order is capped at a 7-day supply, with the prescriber’s covering written prescription due within 7 days.
  • District pharmacists may order and administer vaccines under the ACIP schedules when Board-certified — adults 18 and older with valid identification, and children and adolescents ages 3 through 17 with written informed parental consent. A Board-certified pharmacist working under the joint pharmacy and medicine protocol may prescribe and dispense up to a 12-month supply of self-administered hormonal contraceptives. Naloxone follows a bright line: a pharmacist dispenses or distributes it under a written protocol and standing order, but does not prescribe it. And two widely repeated claims are not District law: there is no District e-prescribing mandate, and there is no statutory cap on opioid day supply — the 7-day figure in District law is a prescription-monitoring check trigger, not a prescribing limit.
  • The people rules run on two-year cycles. Pharmacists complete 40 hours of continuing education every two years — at least 10 of them live and no more than 30 by home study — including 2 hours on medication and dispensing errors and 2 hours of LGBTQ cultural competency training. Internship comes in several shapes: a 1,000-hour college-administered program or 1,500 hours of independent practice, with 400 additional distribution-focused hours required since the class of 2014; and a pharmacist may supervise only one intern at a time without prior Board approval. Pharmacy technicians are registered, not licensed, and the District sets no numeric pharmacist-to-technician ratio — the standard is how many technicians and trainees a pharmacist can safely supervise. A District pharmacy answers to a pharmacist-in-charge, prescription records are kept five years, and the pharmacy rules state a $500 biennial facility license fee ($400 to register a non-resident pharmacy).

What changes on March 1, 2027

  • From March 1, 2027, NABP replaces the MPJE Competency Statements with a new Content Outline — Pharmacy and Pharmacist Practice 30%, Medication Use Process 30%, Regulatory Authority and Legal Obligations 20%, Pharmacy Operations 20%.
  • Every question in this bank is dual-tagged to both blueprints, so this program’s practice exams re-weight to the new outline when the change takes effect — the questions you are practicing now stay the right questions.

Three things worth knowing

  • One scoring point to be clear about: the 70% figure used inside this program is a practice benchmark only. The real MPJE is pass/fail against a standard NABP does not publish as a raw score, and no percentage — ours or anyone else’s — is the MPJE passing standard.
  • One portability point: MPJE scores are not transferable. (Score transfer belongs to the separate uniform UMPJE, used in 13 other jurisdictions.) This program prepares you for the District of Columbia MPJE specifically.
  • One scope point: the 800-question federal core is the same law every MPJE state tests, but the 700 District of Columbia questions key on District law. If you later seek licensure in another MPJE state, you will need that state’s law exam preparation, not the District’s.

For the detailed walk-through of the exam’s format, scoring and rules, read the District of Columbia MPJE Exam Guide.